| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reverses Squamous Metaplasia and Induces Transitional Differentiation in Normal Human Urothelial Cells
From the Department of Biology,* Jack Birch Unit of Molecular Carcinogenesis, University of York, York; the Department of Pathology, St. James’s University Hospital, Leeds; and the Department of Urology, York Hospital, York, United Kingdom
We observed that in urothelium, both cornifying and noncornifying forms of squamous metaplasia are accompanied by changes in the localization of the nuclear hormone receptors, peroxisome proliferator activated receptor 
(PPAR-) and retinoid X receptor (RXR-
). To obtain objective evidence for a role for PPAR--mediated signaling in urothelial differentiation, we examined expression of the cytokeratin isotypes CK13, CK20, and CK14 as indicators of transitional, terminal transitional, and squamous differentiation, respectively, in cultures of normal human urothelial cells. In control culture conditions, normal human urothelial cells showed evidence of squamous differentiation (CK14+, CK13–, CK20–). Treatment with the high-affinity PPAR- agonist, troglitazone (TZ), resulted in gain of CK13 and loss of CK14 protein expression. The effect of TZ was significantly augmented when the autocrine-stimulated epidermal growth factor receptor pathway was inhibited and this resulted in induction of CK20 expression. The RXR-specific inhibitors PA452, HX531, and HX603 inhibited the TZ-induced CK13 expression, supporting a role for RXR in the induction of CK13 expression. Thus, signaling through PPAR- can mediate transitional differentiation of urothelial cells and this is modulated by growth regulatory programs.
This article has been cited by other articles:
 |
|
 |
|
  F. Ondrey Peroxisome Proliferator-Activated Receptor {gamma} Pathway Targeting in Carcinogenesis: Implications for Chemoprevention Clin. Cancer Res., January 1, 2009; 15(1): 2 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Chapman, G. Kelly, and M. A. Knowles Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells Mol. Cancer Res., July 1, 2008; 6(7): 1154 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schwab, V. Reynders, S. Loitsch, Y. M. Shastri, D. Steinhilber, O. Schroder, and J. Stein PPAR{gamma} is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells Carcinogenesis, July 1, 2008; 29(7): 1407 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chopra, J. Hinley, M. B. Oleksiewicz, and J. Southgate Trans-Species Comparison of PPAR and RXR Expression by Rat and Human Urothelial Tissues Toxicol Pathol, April 1, 2008; 36(3): 485 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Long, V. L. Reynolds, A. Lopez-Martinez, T. E. Ryan, S. L. White, and S. R. Eldridge Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event Toxicol Pathol, February 1, 2008; 36(2): 218 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, Y. Hayashida, Y.-T. Chen, H. He, D. Y. Tseng, M. Alonso, S.-Y. Chen, X. Xi, and S. C. G. Tseng Air Exposure Induced Squamous Metaplasia of Human Limbal Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dominick, M. R. White, T. P. Sanderson, T. van Vleet, S. M. Cohen, L. E. Arnold, M. Cano, S. Tannehill-Gregg, J. D. Moehlenkamp, C. R. Waites, et al. Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPAR{alpha}/{gamma} Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action Toxicol Pathol, December 1, 2006; 34(7): 903 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Dumaual, G. E. Sandusky, P. L. Crowell, and S. K. Randall Cellular Localization of PRL-1 and PRL-2 Gene Expression in Normal Adult Human Tissues J. Histochem. Cytochem., December 1, 2006; 54(12): 1401 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K-M Fung, E N S Samara, C Wong, A Metwalli, R Krlin, B Bane, C Z Liu, J T Yang, J V Pitha, D J Culkin, et al. Increased expression of type 2 3{alpha}-hydroxysteroid dehydrogenase/type 5 17{beta}-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr. Relat. Cancer, March 1, 2006; 13(1): 169 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-X. Liang, M. C. Bosland, H. Huang, R. Romih, S. Baptiste, F.-M. Deng, X.-R. Wu, E. Shapiro, and T.-T. Sun Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement J. Cell Biol., December 5, 2005; 171(5): 835 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Cohen Effects of PPAR{gamma} and Combined Agonists on the Urinary Tract of Rats and Other Species Toxicol. Sci., October 1, 2005; 87(2): 322 - 327. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Signoretti, M. M. Pires, M. Lindauer, J. W. Horner, C. Grisanzio, S. Dhar, P. Majumder, F. McKeon, P. W. Kantoff, W. R. Sellers, et al. p63 regulates commitment to the prostate cell lineage PNAS, August 9, 2005; 102(32): 11355 - 11360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Cross, I. Eardley, H. J. Leese, and J. Southgate A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function Am J Physiol Renal Physiol, August 1, 2005; 289(2): F459 - F468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jenkins, M. Bitner-Glindzicz, S. Malcolm, C.-C. A. Hu, J. Allison, P. J.D. Winyard, A. M. Gullett, D. F.M. Thomas, R. A. Belk, S. A. Feather, et al. De Novo Uroplakin IIIa Heterozygous Mutations Cause Human Renal Adysplasia Leading to Severe Kidney Failure J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2141 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin, R. G. Russell, L. E. Dettin, R. Bai, Z.-L. Wei, A. P. Kozikowski, L. Kopleovich, and R. I. Glazer Peroxisome Proliferator-Activated Receptor {delta} and {gamma} Agonists Differentially Alter Tumor Differentiation and Progression during Mammary Carcinogenesis Cancer Res., May 1, 2005; 65(9): 3950 - 3957. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
